Insider · CIK 0001250105

Robertson Sanford

CIK 0001250105 Name as filed on the most recent filing

Filed as Robertson Sanford (45)

279 transaction lines · from 45 filings · filed 2006-08-09 to 2023-08-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

279 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-08-23 P, Open-market purchase Cassava Sciences IncSAVA 523,500, acquired Open Form 4 filing 0001069530-23-000045
2022-08-12 P, Open-market purchase Cassava Sciences IncSAVA 2,069,000, acquired Open Form 4 filing 0001069530-22-000035
2020-09-18 P, Open-market purchase Cassava Sciences IncSAVA 323,627, acquired Open Form 4 filing 0001069530-20-000059
2020-09-17 P, Open-market purchase Cassava Sciences IncSAVA 1,491,759, acquired Open Form 4 filing 0001069530-20-000055
2020-08-31 S, Open-market sale Salesforce.Com, Inc.CRM 5 lines 4,078,073, disposed Open Form 4 filing 0001127602-20-024599
2020-06-18 S, Open-market sale Salesforce.Com, Inc.CRM 7 lines 4,664,316, disposed Open Form 4 filing 0001127602-20-020088
2019-12-20 P, Open-market purchase Cassava Sciences IncSAVA 932,334, acquired Open Form 4 filing 0001069530-19-000065
2019-12-19 P, Open-market purchase Cassava Sciences IncSAVA 141,754, acquired Open Form 4 filing 0001069530-19-000061
2019-08-29 S, Open-market sale Salesforce.Com, Inc.CRM 3,891,733, disposed Open Form 4 filing 0001127602-19-027776
2018-09-27 P, Open-market purchase Pain Therapeutics IncPTIE 39,708, acquired Open Form 4 filing 0001069530-18-000053
2018-09-26 P, Open-market purchase Pain Therapeutics IncPTIE 32,542, acquired Open Form 4 filing 0001069530-18-000052
2018-09-25 P, Open-market purchase Pain Therapeutics IncPTIE 21,420, acquired Open Form 4 filing 0001069530-18-000052
2018-09-24 P, Open-market purchase Pain Therapeutics IncPTIE 9,380, acquired Open Form 4 filing 0001069530-18-000052
2018-09-13 S, Open-market sale Salesforce COM IncCRM 4,738,851, disposed Open Form 4 filing 0001127602-18-027817
2018-06-11 S, Open-market sale Salesforce COM IncCRM 4,021,617, disposed Open Form 4 filing 0001127602-18-020835
2014-07-31 S, Open-market sale Dolby Laboratories, Inc.DLB 1,120,333, disposed Open Form 4 filing 0001181431-14-028085
2014-07-30 S, Open-market sale Dolby Laboratories, Inc.DLB 1,662,415, disposed Open Form 4 filing 0001181431-14-028085
2013-11-06 P, Open-market purchase Pain Therapeutics IncPTIE 119,711, acquired Open Form 4 filing 0001573723-13-000021
2013-11-04 P, Open-market purchase Pain Therapeutics IncPTIE 67,018, acquired Open Form 4 filing 0001573723-13-000021
2013-08-02 P, Open-market purchase RPX CorpRPXC 166,489, acquired Open Form 4 filing 0001509432-13-000099
2013-02-27 P, Open-market purchase RPX CorpRPXC 641,740, acquired Open Form 4 filing 0001219119-13-000027
2012-12-17 S, Open-market sale Salesforce COM IncCRM 3,707,444, disposed Open Form 4 filing 0001127602-12-034206
2012-12-14 S, Open-market sale Salesforce COM IncCRM 2,965,653, disposed Open Form 4 filing 0001127602-12-034206
2012-12-05 S, Open-market sale Salesforce COM IncCRM 124,721, disposed Open Form 4 filing 0001127602-12-033004
2012-09-13 S, Open-market sale Salesforce COM IncCRM 1,541,794, disposed Open Form 4 filing 0001127602-12-026283
2011-11-11 P, Open-market purchase RPX CorpRPXC 305,573, acquired Open Form 4 filing 0001181431-11-056052
2011-11-10 P, Open-market purchase RPX CorpRPXC 402,324, acquired Open Form 4 filing 0001181431-11-056052
2011-05-12 S, Open-market sale Dolby Laboratories, Inc.DLB 498,783, disposed Open Form 4 filing 0001181431-11-029724
2010-12-09 S, Open-market sale Salesforce COM IncCRM 2,993,784, disposed Open Form 4 filing 0001127602-10-030154
2010-06-11 S, Open-market sale Salesforce COM IncCRM 280,374, disposed Open Form 4 filing 0001127602-10-017090
2010-05-04 S, Open-market sale Dolby Laboratories, Inc.DLB 674,933, disposed Open Form 4 filing 0001181431-10-024630
2010-03-22 S, Open-market sale Salesforce COM IncCRM 3,729,500, disposed Open Form 4 filing 0001127602-10-009283
2009-12-01 S, Open-market sale Salesforce COM IncCRM 94,365, disposed Open Form 4 filing 0001127602-10-015381
2009-10-15 P, Open-market purchase Pain Therapeutics IncPTIE 100,000, acquired Open Form 4 filing 0001245261-09-000021
2009-09-11 S, Open-market sale Salesforce COM IncCRM 6 lines 2,900,162, disposed Open Form 4 filing 0001127602-09-018815

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 18
  • Open-market sale 261
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. ROBERTSON SANFORD, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001250105

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.